Buy MITOMYCIN FOR INJECTION, USP 20 MG MITOMYCIN

Mitomycin for Injection, USP 20 MG is a powder for solution used for intravenous administration. This medication is commonly associated with certain types of cancer treatments. It is manufactured by Hikma Canada Limited.

Strength

20 MG

Manufacturer / TM Owner

HIKMA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Mitomycin for Injection, USP 20 MG is generally used in the treatment of specific types of cancer. It works by interfering with the growth of cancer cells. This medication may be prescribed for various cancer-related conditions, and its use should be determined by a healthcare professional.

Side Effects

Common effects of Mitomycin for Injection, USP 20 MG may include nausea, vomiting, and fatigue. Some individuals may experience more severe side effects, which should be discussed with a healthcare provider. It is important to monitor for any unusual symptoms while using this medication.

Precautions & Warnings

Mitomycin for Injection, USP 20 MG should be handled with care, as it is a potent medication. It is crucial to follow the preparation and administration instructions provided by a healthcare professional. This medication should be stored and disposed of properly to ensure safety.

Avoid Interactions

Mitomycin for Injection, USP 20 MG may interact with other medications, including certain chemotherapy drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of this medication.

References

Frequently Asked Questions

Mitomycin for Injection, USP 20 MG is commonly used in the treatment of specific types of cancer. It interferes with the growth of cancer cells.

Mitomycin for Injection, USP 20 MG is administered intravenously after being prepared as a solution from the powder form.

Common side effects may include nausea, vomiting, and fatigue. Severe side effects should be discussed with a healthcare provider.

Yes, Mitomycin for Injection, USP 20 MG may interact with other medications, particularly certain chemotherapy drugs. Always inform your healthcare provider about all medications you are taking.

Mitomycin for Injection, USP 20 MG should be stored according to the instructions provided by the manufacturer and healthcare professional to ensure its stability and safety.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.